Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Ocugen Completes Dosing of Stargardt Disease Patients in Phase 1/2 GARDIAN Trial for OCU410ST Gene Therapy
Thursday, May 16, 2024Ocugen Inc a biotechnology company focused on developing novel gene and cell therapies as well as vaccines has announced the completion of dosing in the second cohort of its Phase GARDian clinical trial
Ractigen Therapeutics Receives Approval from China’s NMPA to Commence Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients
Thursday, May 16, 2024Ractigen Therapeutics a leading clinicalstage pharmaceutical company dedicated to developing innovative therapies has announced a significant achievement the approval of its Investigational New Drug
Arexvy, the First RSV Vaccine for Older Adults, Granted Approval by HSA
Thursday, May 16, 2024Arexvy the worlds first respiratory syncytial virus vaccine has recently gained approval from the Health Sciences Authority of Singapore for immunizing individuals aged years and above against lower respiratory tract disease caused by RSV This groun...
Zai Lab's Application for Priority Review of Efgartigimod Alfa Injection Accepted for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
Wednesday, May 15, 2024Zai Lab Limited has announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted the supplemental Biologics License Application
Everest Medicines Introduces NEFECON® to Mainland China with Commercial Launch and First Prescription
Wednesday, May 15, 2024Everest Medicines a biopharmaceutical company dedicated to advancing medicines and vaccines has announced the successful launch of NEFECON in China marking a significant advancement
HUTCHMED Commences RAPHAEL Registrational Phase III Trial of HMPL-306 for Chinese Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia
Tuesday, May 14, 2024HUTCHMED Limited has initiated a Phase III clinical trial for HMPL in Chinese patients with relapsed
Mabwell Updates on Clinical Trial Development of 9MW2821 for Triple-Negative Breast Cancer
Tuesday, May 14, 2024Mabwell an innovative biopharmaceutical company with a comprehensive industry chain has provided updates on the clinical study progress of its groundbreaking ADC targeting Nectin for triplenegative
Launch of Tiopronin Delayed-Release Tablets with Patient Support for Cystinuria Treatment in the United States
Tuesday, May 14, 2024Cycle Pharmaceuticals Limited is excited to introduce tiopronin delayedrelease tablets as a treatment option for individuals with cystinuria Tiopronin delayedrelease tablets come in mg and mg doses
Dupixent (Dupilumab) Under FDA Priority Review for Adolescent Chronic Rhinosinusitis with Nasal Polyposis Treatment
Monday, May 13, 2024Regeneron Pharmaceuticals Inc and Sanofi have shared a significant update regarding the potential treatment of adolescents grappling with inadequately controlled chronic rhinosinusitis
QIAGEN's Syndromic QIAstat-Dx Test Granted FDA Clearance for Rapid and Accurate Respiratory Disease Diagnosis
Monday, May 13, 2024QIAGEN has announced that the US Food and Drug Administration has approved the clinical use of the QIAstatDx Respiratory Panel Plus for syndromic testing
